Skip to main content
Clinical Trials/NCT06748339
NCT06748339
Completed
Not Applicable

Gut Microbiome Dyspiosis in Colorectal Cancer Egyptian Patients

Heliopolis University1 site in 1 country18 target enrollmentJanuary 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colorectal Cancer
Sponsor
Heliopolis University
Enrollment
18
Locations
1
Primary Endpoint
The effect of food and lifestyle on microbiome
Status
Completed
Last Updated
last year

Overview

Brief Summary

Colorectal cancer (CRC) is reported to be the third leading cause of cancer deaths worldwide, and its prevalence is steadily rising in developing countries. It can be considered a marker of socioeconomic development and a marker of significant changes in food habits and lifestyle. In Egypt, CRC represents the seventh most common cancer. It is the third most reported cancer in males and the fifth most common cancer in females. microbiome dysbiosis may be involved in the pathogensis and thus pose a therapeutic target

Detailed Description

Many reports suggested the role of westernized dietary lifestyles, including high consumption of red meats, animal fats, and cholesterol-rich foods, as well as smoking, decreased physical activity, obesity, diabetes, alcohol consumption, or smoking, in CRC development. These changes in lifestyle are called the external factors, which are now linked to changes in the inner gut microenvironments, mainly the microbiomes. Our aim is to investigate the the changes in microbiome profile in relation to clinical, pathological and lifestyle factors

Registry
clinicaltrials.gov
Start Date
January 1, 2024
End Date
December 17, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Heliopolis University
Responsible Party
Principal Investigator
Principal Investigator

Sara mostafa ElAdawy

lecturer

Heliopolis University

Eligibility Criteria

Inclusion Criteria

  • Age of 40 years to 80 years
  • Patients with a newly diagnosed CRC

Exclusion Criteria

  • Patients with previously known CRC
  • Pregnancy or Lactation
  • Abdominal surgery within/up to 6 months prior to sample collection
  • Antibiotics, corticosteroids, or probiotics up to three months prior to sample collection
  • History of other types of cancer
  • Subjects on a special diet
  • Diabetes, liver, or kidney diseases
  • CRC patients who used enema or underwent colonoscopy up to one week before sample collection.

Outcomes

Primary Outcomes

The effect of food and lifestyle on microbiome

Time Frame: "through study completion, an average of 1 year"

correlation between food and lifestyle with microbiome profiles

microbiome profile and CRC pathogensis

Time Frame: "through study completion, an average of 1 year"

correlation between microbiome profile and CRC pathogensis

Study Sites (1)

Loading locations...

Similar Trials